On July 31, 2026, Dudley Lamming, a professor of medicine at the University of Wisconsin-Madison, published a review of more than 350 studies in the journal Cell Press Blue. The paper found that cutting protein intake — specifically three amino acids called methionine, isoleucine, and valine — activates biological pathways linked to longer, healthier aging. The mechanisms include a rise in a hormone called FGF21, which increases energy expenditure and improves blood sugar control, and suppression of mTOR, a growth signal that drives cellular aging when chronically activated. Americans currently consume about 80 grams of protein per day, roughly 40% above the current recommended daily intake — in a country where high-protein diets have ranked as the most popular diet trend for three years running.

1. Cutting Protein Could Add Years (Dudley Lamming, Valter Longo)

Most sedentary adults are eating more protein than they need, and the excess may be speeding up their aging.

Excess protein fires up cellular machinery that drives aging. Lamming argues that methionine, isoleucine, and valine — three amino acids abundant in meat, dairy, and eggs — activate mTOR, a signaling pathway that promotes growth in young, active bodies but accelerates biological aging in people who aren't exercising enough to burn through that signal. His prior lab work found that restricting just isoleucine extended male mice's lives by 33%. "It's absolutely crystal clear that there are benefits of protein to muscle growth and exercise response of active individuals," he says. "But because most people are relatively sedentary, many people are likely consuming more protein than they actually need, which probably has negative health consequences."

A drop in protein also triggers a protective hormone. When protein intake falls, the body raises FGF21 levels. In mice, higher FGF21 correlated with longer lifespans — with stronger effects in males. The hormone increases energy expenditure, improves blood glucose, and reduces inflammation. Lamming says sedentary adults should probably stick to the original recommended intake of 0.8 grams per kilogram of body weight — lower than what most Americans eat.

People eating less animal protein had lower cancer and diabetes rates. Valter Longo, a professor of gerontology and biological sciences at the University of Southern California, analyzed data from more than 200,000 people and found those eating the most animal protein had higher obesity rates and twice the diabetes prevalence. Longo links low protein intake to sharply lower IGF-1, cancer risk, and overall mortality — but only in adults under 65, not in older adults. His recommended diet: legumes, whole grains, vegetables, and some fish, with very little red or processed meat.

2. Older Adults Need More Protein, Not Less (Stuart Phillips, Donald Layman)

Sarcopenia — muscle loss with age — is a serious clinical problem, and lower protein makes it worse.

Aging muscles stop responding to protein as efficiently. Stuart Phillips, a Distinguished University Professor at McMaster University and Tier 1 Canada Research Chair in Skeletal Muscle Health, calls this "anabolic resistance." As the body ages, muscles need more protein to trigger the same repair response. Phillips recommends around 1.2 grams per kilogram per day for older adults — 50% above the current RDA. Phillips notes that sarcopenia "begins earlier than many realize — often as early as age 35."

Leucine in particular is essential for triggering muscle repair at every meal. Donald Layman, professor emeritus of food science and human nutrition at the University of Illinois Urbana-Champaign, has argued for decades that older adults need consistent leucine intake at each sitting to stimulate muscle protein synthesis. Leucine is a branched-chain amino acid — the same category the Lamming review flags as potentially harmful in excess. Layman says aging is "a clear indication for an increase in dietary protein."

Most older adults fall into the review's own exceptions. Lamming's review explicitly carves out pregnant women and older adults with sarcopenia as groups that may need higher protein. It also notes that athletes on high-protein diets don't show the same negative metabolic effects — suggesting exercise changes the equation. The high-protein camp argues this concession settles the debate. They say that once you carve out older adults and active people, almost no one remains in the "cut protein" group.

3. The Science Comes Mostly from Mice (Paul Greenhaff, Kevin McConway)

Most of the 350 studies weren't on humans — and organisms that live a few weeks don't age the way people do.

This is a narrative review, not a study with new data. Kevin McConway, emeritus professor of applied statistics at the Open University, points out that press releases about the paper described it as a "systematic review," which follows strict protocols about which studies to include. "It simply isn't," McConway says. It's a narrative review, meaning the authors chose which evidence to highlight. McConway notes that much of that evidence "comes from non-human organisms."

What works in mice doesn't automatically work in people. Paul Greenhaff, professor of muscle metabolism at the University of Nottingham, argues that yeast, fruit flies, and rodents age through mechanisms that don't adequately represent human biology. "Whether they translate to the human condition is debatable," Greenhaff says. The 2014 Levine et al. study in Cell Metabolism found that low protein reduced mortality in adults under 65 — but raised mortality in adults over 65. The Lamming review doesn't resolve that paradox; it adds more evidence on one side of it.

Where This Lands

Lamming and Longo argue that most sedentary Americans are eating more protein than their bodies can use well, and the excess keeps aging signals chronically elevated. Phillips and Layman say the danger for the growing population of older adults runs the other way: too little protein and muscles waste away, frailty sets in, and the downstream health consequences are real. Greenhaff and McConway say neither side has the human trial data to draw firm conclusions, and that the review's media coverage outruns its human evidence. The protein supplement industry, worth $31.9 billion and growing at 10% a year, hasn't changed its message.

Sources